Insiders · Profile

Morosini Deborah

EVP, Chief of Clinical Affairs at Prelude Therapeutics. Filing since 29 Sep 2020. CIK 0001824625

Company
Date
Role
Action
Shares
Amount
Of holding
15 Dec 2021
EVP, Chief of Clinical Affairs
Sold, plan not stated
28,751
$373.76K
98.5%
16 Nov 2021
EVP, Chief of Clinical Affairs
Sold, plan not stated
28,751
$456.53K
98.5%
29 Apr 2021
EVP, Chief of Clinical Affairs
Sold, plan not stated
3,223
$129.85K
87.9%
8 Apr 2021
EVP, Chief of Clinical Affairs
Sold, plan not stated
100
$4.00K
18.4%
7 Apr 2021
EVP, Chief of Clinical Affairs
Sold, plan not stated
1,000
$40.04K
69.3%
29 Sep 2020
EVP, Chief of Clinical Affairs
Bought
444
$8.44K
opened
6 decisions on file.